Joimax has launched its new iLESSYS biportal interlaminar endoscopic surgical system for the treatment of spinal disorders at the recent EUROSPINE 2023 (4–6 October, Frankfurt, Germany) and Society for Minimally Invasive Spine Surgery (SMISS; 5–7 October, Las Vegas, USA) annual meetings, marking its global debut.
It is also being presented at this week’s North American Spine Society (NASS) annual meeting (18–21 October, Los Angeles, USA).
The new instrument set, iLESSYS Biportal for unilateral biportal endoscopy (UBE), expands the wide range of Joimax endoscopic offerings by separating the instrument working port from the endoscope, allowing for free relative movement between the two—according to a company press release.
The iLESSYS Biportal offers all instruments tailor-made for biportal spinal endoscopy, with:
- A special triangulation tool to simplify the access triangulation of two ports
- Biportal specific working tubes with inbuilt irrigation outflow control for precise water management
- Larger, more powerful tools for effective tissue ablation and resection
“This system is excellent and will allow me to perform the surgeries not only biportally but also bimanually,” stated Javier Quillo-Olvera (Brain and Spine Care Group, Querétaro, Mexico). “It allows me to use the iLESSYS Pro working channel endoscope. I am excited to use it with my patients.”
EUROSPINE attendees were “impressed” that this comprehensive system could be used as a biportal system and available for bimanual surgical procedures, Joimax claims. Moreover, the iLESSYS played a key role during the expert talks, spurring debate about when to use the transforaminal (TESSYS) and when to use the interlaminar (iLESSYS) approach for a given spinal disease.
